BMY |
Bristol-Myers Squibb Company |
118.10B |
7.89% |
|
|
|
|
|
58.23 |
0.60% |
23.40% |
18.97% |
---|
PFE |
Pfizer Inc. |
142.41B |
7.44% |
|
|
|
|
|
25.13 |
0.76% |
29.73% |
67.95% |
---|
JNJ |
Johnson & Johnson |
374.38B |
7.36% |
|
|
|
|
|
155.50 |
1.56% |
18.20% |
30.35% |
---|
ABBV |
AbbVie Inc. |
303.47B |
7.26% |
|
|
|
|
|
171.73 |
2.37% |
21.29% |
28.02% |
---|
MRK |
Merck & Co., Inc. |
252.61B |
6.66% |
|
|
|
|
|
99.86 |
2.48% |
24.01% |
49.79% |
---|
GILD |
Gilead Sciences, Inc. |
111.87B |
4.27% |
|
|
|
|
|
89.76 |
1.28% |
25.38% |
34.41% |
---|
CAH |
Cardinal Health, Inc. |
29.87B |
3.73% |
|
|
|
|
|
123.42 |
2.56% |
23.50% |
35.91% |
---|
ZTS |
Zoetis Inc. |
79.73B |
3.72% |
|
|
|
|
|
176.71 |
0.59% |
22.61% |
7.97% |
---|
AMGN |
Amgen Inc. |
155.83B |
3.60% |
|
|
|
|
|
289.90 |
0.71% |
51.85% |
92.17% |
---|
VTRS |
Viatris Inc. |
15.82B |
3.59% |
|
|
|
|
|
13.25 |
0.91% |
32.48% |
9.75% |
---|
LLY |
Eli Lilly and Company |
711.91B |
3.52% |
|
|
|
|
|
749.92 |
-0.46% |
39.04% |
42.37% |
---|
UTHR |
United Therapeutics Corporation |
16.40B |
3.52% |
|
|
|
|
|
367.36 |
0.83% |
34.18% |
76.88% |
---|
BIIB |
Biogen Inc. |
23.03B |
3.37% |
|
|
|
|
|
158.01 |
1.29% |
30.76% |
40.69% |
---|
JAZZ |
Jazz Pharmaceuticals plc |
7.56B |
3.04% |
|
|
|
|
|
125.10 |
4.91% |
45.21% |
40.60% |
---|
REGN |
Regeneron Pharmaceuticals, Inc. |
80.46B |
2.99% |
|
|
|
|
|
744.50 |
0.15% |
30.82% |
65.68% |
---|
OGN |
Organon & Co. |
3.83B |
2.72% |
|
|
|
|
|
14.89 |
1.09% |
44.42% |
47.52% |
---|
CRL |
Charles River Laboratories International... |
9.93B |
2.29% |
|
|
|
|
|
194.19 |
3.35% |
37.00% |
47.50% |
---|
MEDP |
Medpace Holdings, Inc. |
10.62B |
1.77% |
|
|
|
|
|
341.82 |
4.82% |
35.91% |
32.65% |
---|
ELAN |
Elanco Animal Health Incorporated |
6.62B |
1.62% |
|
|
|
|
|
13.40 |
-0.30% |
37.96% |
19.30% |
---|
NBIX |
Neurocrine Biosciences, Inc. |
12.66B |
1.31% |
|
|
|
|
|
125.00 |
1.39% |
26.05% |
22.51% |
---|
HALO |
Halozyme Therapeutics, Inc. |
5.81B |
1.09% |
|
|
|
|
|
45.70 |
-0.13% |
49.04% |
51.89% |
---|
ALKS |
Alkermes plc |
4.48B |
0.98% |
|
|
|
|
|
27.70 |
-0.75% |
36.13% |
55.87% |
---|
PRGO |
Perrigo Company plc |
3.69B |
0.91% |
|
|
|
|
|
27.08 |
-0.26% |
38.73% |
31.78% |
---|
EXEL |
Exelixis, Inc. |
9.95B |
0.89% |
|
|
|
|
|
34.83 |
0.52% |
30.45% |
21.53% |
---|
PBH |
Prestige Consumer Healthcare Inc. |
4.16B |
0.86% |
|
|
|
|
|
84.14 |
1.78% |
39.97% |
29.36% |
---|
PTGX |
Protagonist Therapeutics, Inc. |
2.48B |
0.81% |
|
|
|
|
|
41.65 |
2.46% |
63.59% |
23.14% |
---|
ALNY |
Alnylam Pharmaceuticals, Inc. |
31.83B |
0.71% |
|
|
|
|
|
246.80 |
-0.80% |
45.69% |
29.50% |
---|
CORT |
Corcept Therapeutics Incorporated |
5.86B |
0.71% |
|
|
|
|
|
55.92 |
-0.30% |
67.93% |
30.36% |
---|
ACLX |
Arcellx, Inc. |
4.72B |
0.65% |
|
|
|
|
|
87.22 |
0.00% |
67.64% |
41.52% |
---|
VKTX |
Viking Therapeutics, Inc. |
5.75B |
0.64% |
|
|
|
|
|
51.63 |
0.19% |
87.77% |
18.11% |
---|
EXAS |
Exact Sciences Corporation |
9.82B |
0.59% |
|
|
|
|
|
53.07 |
0.70% |
46.35% |
12.05% |
---|
ITCI |
Intra-Cellular Therapies, Inc. |
9.06B |
0.55% |
|
|
|
|
|
85.45 |
-0.22% |
32.01% |
9.86% |
---|
RNA |
Avidity Biosciences, Inc. |
5.08B |
0.54% |
|
|
|
|
|
42.56 |
-2.50% |
68.20% |
11.58% |
---|
TGTX |
TG Therapeutics, Inc. |
5.38B |
0.52% |
|
|
|
|
|
34.55 |
10.91% |
76.64% |
48.95% |
---|
KYMR |
Kymera Therapeutics, Inc. |
2.82B |
0.52% |
|
|
|
|
|
43.51 |
-1.23% |
60.06% |
36.99% |
---|
INCY |
Incyte Corporation |
13.56B |
0.52% |
|
|
|
|
|
70.39 |
-0.93% |
52.27% |
70.92% |
---|
ROIV |
Roivant Sciences Ltd. |
8.60B |
0.51% |
|
|
|
|
|
11.82 |
2.87% |
31.83% |
30.08% |
---|
AMRX |
Amneal Pharmaceuticals, Inc. |
3.84B |
0.51% |
|
|
|
|
|
8.32 |
-1.07% |
141.67% |
48.35% |
---|
SRPT |
Sarepta Therapeutics, Inc. |
10.55B |
0.51% |
|
|
|
|
|
110.50 |
-0.32% |
41.90% |
7.61% |
---|
VRTX |
Vertex Pharmaceuticals Incorporated |
115.98B |
0.51% |
|
|
|
|
|
450.37 |
-0.19% |
47.79% |
93.02% |
---|
TWST |
Twist Bioscience Corporation |
2.44B |
0.50% |
|
|
|
|
|
41.66 |
1.34% |
65.97% |
23.78% |
---|
INSM |
Insmed Incorporated |
13.20B |
0.49% |
|
|
|
|
|
73.81 |
1.57% |
52.85% |
9.63% |
---|
ADMA |
ADMA Biologics, Inc. |
5.04B |
0.48% |
|
|
|
|
|
21.30 |
-0.33% |
51.76% |
4.82% |
---|
KRYS |
Krystal Biotech, Inc. |
5.24B |
0.47% |
|
|
|
|
|
182.29 |
2.35% |
42.72% |
35.46% |
---|
ACAD |
ACADIA Pharmaceuticals Inc. |
2.69B |
0.46% |
|
|
|
|
|
16.18 |
-0.55% |
59.88% |
30.50% |
---|
BPMC |
Blueprint Medicines Corporation |
6.14B |
0.46% |
|
|
|
|
|
96.62 |
1.91% |
49.15% |
17.43% |
---|
BMRN |
BioMarin Pharmaceutical Inc. |
12.09B |
0.45% |
|
|
|
|
|
63.45 |
1.42% |
31.72% |
30.63% |
---|
VCEL |
Vericel Corporation |
2.80B |
0.45% |
|
|
|
|
|
56.71 |
-0.96% |
55.01% |
23.93% |
---|
IONS |
Ionis Pharmaceuticals, Inc. |
5.36B |
0.43% |
|
|
|
|
|
33.94 |
-4.12% |
44.84% |
38.77% |
---|
MYGN |
Myriad Genetics, Inc. |
1.38B |
0.40% |
|
|
|
|
|
15.12 |
-1.18% |
53.88% |
59.47% |
---|
|
US Dollar |
|
0.24% |
|
|
|
|
|
|
|
|
|
---|